help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-1509
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Ophoff, J.
Right arrow Articles by Vanderschueren, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ophoff, J.
Right arrow Articles by Vanderschueren, D.
Endocrinology Vol. 150, No. 8 3558-3566
Copyright © 2009 by The Endocrine Society

Androgen Signaling in Myocytes Contributes to the Maintenance of Muscle Mass and Fiber Type Regulation But Not to Muscle Strength or Fatigue

Jill Ophoff1, Karen Van Proeyen1, Filip Callewaert, Karel De Gendt, Katrien De Bock, An Vanden Bosch, Guido Verhoeven, Peter Hespel2 and Dirk Vanderschueren2

Laboratory for Experimental Medicine and Endocrinology (J.O., F.C., K.D.G., A.V.B., G.V., D.V.), Department of Experimental Medicine, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; and Research Center for Exercise and Health (K.V.P., K.D.B., P.H.), Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, 3001 Heverlee, Belgium

Address all correspondence and requests for reprints to: Dirk Vanderschueren, Laboratory for Experimental Medicine and Endocrinology, Herestraat 49 B-3000 Leuven, Belgium. E-mail: Dirk.Vanderschueren{at}uz.kuleuven.be.

Muscle frailty is considered a major cause of disability in the elderly and chronically ill. However, the exact role of androgen receptor (AR) signaling in muscle remains unclear. Therefore, a postmitotic myocyte-specific AR knockout (mARKO) mouse model was created and investigated together with a mouse model with ubiquitous AR deletion. Muscles from mARKO mice displayed a marked reduction in AR protein (60–88%). Interestingly, body weights and lean body mass were lower in mARKO vs. control mice (–8%). The weight of the highly androgen-sensitive musculus levator ani was significantly reduced (–46%), whereas the weights of other peripheral skeletal muscles were not or only slightly reduced. mARKO mice had lower intra-abdominal fat but did not demonstrate a cortical or trabecular bone phenotype, indicating that selective ablation of the AR in myocytes affected male body composition but not skeletal homeostasis. Furthermore, muscle contractile performance in mARKO mice did not differ from their controls. Myocyte-specific AR ablation resulted in a conversion of fast toward slow fibers, without affecting muscle strength or fatigue. Similar results were obtained in ubiquitous AR deletion, showing lower body weight, whereas some but not all muscle weights were reduced. The percent slow fibers was increased, but no changes in muscle strength or fatigue could be detected. Together, our findings show that myocyte AR signaling contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. The levator ani weight remains the most sensitive and specific marker of AR-mediated anabolic action on muscle.




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. E. MacLean and D. J. Handelsman
Unraveling Androgen Action in Muscle: Genetic Tools Probing Cellular Mechanisms
Endocrinology, August 1, 2009; 150(8): 3437 - 3439.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society